Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$36.86 - $44.5 $821,978 - $992,350
-22,300 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$40.32 - $50.97 $82,010 - $103,672
-2,034 Reduced 8.36%
22,300 $931,000
Q4 2020

Feb 02, 2021

SELL
$41.72 - $51.34 $20,860 - $25,670
-500 Reduced 2.01%
24,334 $1.13 Million
Q3 2020

Nov 05, 2020

SELL
$37.02 - $51.28 $2,147 - $2,974
-58 Reduced 0.23%
24,834 $1.06 Million
Q2 2020

Aug 12, 2020

BUY
$43.24 - $55.02 $186,494 - $237,301
4,313 Added 20.96%
24,892 $1.19 Million
Q1 2020

May 12, 2020

SELL
$34.37 - $60.07 $1.23 Million - $2.14 Million
-35,695 Reduced 63.43%
20,579 $947,000
Q4 2019

Jan 27, 2020

BUY
$54.32 - $64.31 $2.79 Million - $3.31 Million
51,395 Added 1053.39%
56,274 $3.38 Million
Q3 2019

Oct 31, 2019

BUY
$53.25 - $59.98 $259,806 - $292,642
4,879 New
4,879 $276,000
Q4 2018

Feb 08, 2019

SELL
$36.72 - $67.73 $109,058 - $201,158
-2,970 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$66.65 - $83.86 $14,396 - $18,113
216 Added 7.84%
2,970 $206,000
Q2 2018

Aug 15, 2018

BUY
$51.25 - $76.62 $141,142 - $211,011
2,754 New
2,754 $208,000

Others Institutions Holding EGRX

About EAGLE PHARMACEUTICALS, INC.


  • Ticker EGRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 13,015,900
  • Market Cap $7.81M
  • Description
  • Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...
More about EGRX
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.